Obalon Announces Repayment of All Long-Term Debt and Regaining of Compliance with NASDAQ Listing Requirement
“We are pleased to continue to transform the Company’s financial position and believe that with no long-term debt and our current cash position we are well-positioned to drive our strategy to bring the Obalon Balloon System to patients in need of a proven weight loss solution,” said
To the extent that statements contained in this press release are not descriptions of historical facts regarding
President & Chief Financial Officer
Office: +1 760 607 5103
Source: Obalon Therapeutics, Inc.